DOJ reportedly preparing suits against Aetna-Humana, Anthem-Cigna mergers

Reuters and Bloomberg have reported the U.S. Department of Justice (DOJ) will soon file lawsuits to block two pending mergers between major health insurers: Anthem’s acquisition of Cigna and Aetna’s takeover of Humana.

Both stories cite “sources familiar with the matter,” who said the DOJ is concerned about healthcare costs increasing if four of the five largest insurers in the U.S. consolidate. A July 8 report from Reuters said the DOJ had “significant concerns” about the Aetna-Humana deal, and since then, Aetna has begun looking for buyers for its Medicare Advantage business to ease antitrust concerns. According to Bloomberg, those efforts aren’t likely satisfy federal officials.

The rumored DOJ lawsuits would be exactly what several groups of politicians and state regulators have requested over the past several months:

  • On May 24, Missouri’s insurance department issued an order against the Aetna-Humana merger over its “anticompetitive impact."
  • On June 16, California Insurance Commissioner Dave Jones asked the DOJ to block the Anthem-Cigna deal, saying “More competition in California's consolidated health insurance markets is needed, not less.”
  • On June 22, seven Democratic U.S. Senators wrote a letter to the DOJ asking it to challenge the deals, arguing the result will be higher premiums and reduced access to care.

Not all state agencies have opposed the deal—18 state insurance regulators signed off on the Aetna-Humana deal, and another 10 approved the Anthem-Cigna merger.

“We are steadfast in our belief that this deal is good for consumers and the health-care system as a whole,” T.J. Crawford, an Aetna spokesman, said to Bloomberg.

Bloomberg's and Reuters’ sources indicate the suits could be filed as early as next week. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”